Evidence map›Paper›PMID 37560924›Full record

ArticleJournal of virology2023

Deep spatial profiling of Venezuelan equine encephalitis virus reveals increased genetic diversity amidst neuroinflammation and cell death during brain infection.

Evan P Williams, Yi Xue, Jasper Lee, Elizabeth A Fitzpatrick, Ying Kong, Walter Reichard, Haley Writt, Colleen B Jonsson

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Evan P WilliamsDepartment of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center , Memphis, Tennessee, USA.ORCID 0000-0003-4506-115X
Yi XueDepartment of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center , Memphis, Tennessee, USA.
Jasper LeeDepartment of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center , Memphis, Tennessee, USA.
Elizabeth A FitzpatrickDepartment of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center , Memphis, Tennessee, USA.
Ying KongDepartment of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center , Memphis, Tennessee, USA.
Walter ReichardDepartment of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center , Memphis, Tennessee, USA.
Haley WrittDepartment of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center , Memphis, Tennessee, USA.
Colleen B JonssonDepartment of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center , Memphis, Tennessee, USA.ORCID 0000-0002-2640-7672
University of Tennessee Health Science Center · US

Funding

Medicinal Chemistry Optimization of Anti-Alphaviral Leads and Elucidation of Target and Off Target EngagementU19AI142762 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI JONSSON, COLLEEN B · 2019 to 2023
$22.0M
NIAID NIH HHS U19 AI142762
6 · The paper itself

Abstract

Venezuelan equine encephalitis virus (VEEV) causes a febrile illness that can progress to neurological disease with the possibility of death in human cases. The evaluation and optimization of therapeutics that target brain infections demands knowledge of the host's response to VEEV, the dynamics of infection, and the potential for within-host evolution of the virus. We hypothesized that selective pressures during infection of the brain may differ temporally and spatially and so we investigated the dynamics of the host response, viral transcript levels, and genetic variation of VEEV TC-83 in eight areas of the brain in mice over 7 days post-infection (dpi). Viral replication increased throughout the brain until 5-6 dpi and decreased thereafter with neurons as the main site of viral replication. Low levels of genetic diversity were noted on 1 dpi and were followed by an expansion in the genetic diversity of VEEV and nonsynonymous (Ns) mutations that peaked by 5 dpi. The pro-inflammatory response and the influx of immune cells mirrored the levels of virus and correlated with substantial damage to neurons by 5 dpi and increased activation of microglial cells and astrocytes. The prevalence and dynamics of Ns mutations suggest that the VEEV is under selection within the brain and that progressive neuroinflammation may play a role in acting as a selective pressure. IMPORTANCE Treatment of encephalitis in humans caused by Venezuelan equine encephalitis virus (VEEV) from natural or aerosol exposure is not available, and hence, there is a great interest to address this gap. In contrast to natural infections, therapeutic treatment of infections from aerosol exposure will require fast-acting drugs that rapidly penetrate the blood-brain barrier, engage sites of infection in the brain and mitigate the emergence of drug resistance. Therefore, it is important to understand not only VEEV pathogenesis, but the trafficking of the viral population within the brain, the potential for within-host evolution of the virus, and how VEEV might evolve resistance.

Indexed as

EncephalitisEncephalitis Virus, Venezuelan EquineAnimalsBrainCell DeathGenetic VariationHumansMicebrainimmune responsemicenonsynonymous mutationspathologyRNA sequencingVenezuelan encephalitis virus

Identifiers

PMID37560924
PMCPMC10506382
OpenAlexW4385716433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.